Glenmark Pharma breaks out; Analyst sees ₹2,300 resistance
Glenmark surged 20% in a week, backed by record volume and strong technicals. SEBI RA Vijay Gupta flagged a breakout above the Ichimoku cloud with bullish crossovers. Despite a USFDA warning for its Indore plant, Glenmark expects no material impact. Resistance lies at ₹2,280-2,300; support at ₹1,960. Momentum traders are advised to buy dips, not chase highs.